Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares the efficacy and safety of bimekizumab versus ustekinumab in children and adolescents aged 6 to under 18 with moderate to s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate to Severe Plaque Psoriasis | Phase 3 | Status: RECRUITING